Janus Henderson Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.8M Sell
6,032,650
-2,403,991
-28% -$8.05M 0.01% 664
2025
Q4
$33.6M Buy
8,436,641
+445,264
+6% +$1.97M 0.02% 496
2025
Q3
$30.3M Buy
+7,991,377
New +$27.1M 0.01% 521

Other funds holding NBP

Janus Henderson Group's NBP Position: Q1 2026 in Review

Janus Henderson Group reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 28% in Q1 2026, selling an estimated $8.05M and leaving 6,032,650 shares worth $14.8M. The position accounts for 0.01% of the portfolio, ranked #664.

Janus Henderson Group first reported a position in NBP in Q3 2025 and has held it in 3 quarters since. The position peaked at $33.6M in Q4 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Janus Henderson Group held 6,032,650 shares of NovaBridge Biosciences American Depositary Shares worth $14.8M as of Q1 2026.
  • Janus Henderson Group sold 2,403,991 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $8.05M.
  • NovaBridge Biosciences American Depositary Shares made up 0.01% of Janus Henderson Group's portfolio in Q1 2026, its #664 holding.
  • Janus Henderson Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2025 and has held it in 3 quarters since.
  • Janus Henderson Group's NovaBridge Biosciences American Depositary Shares position peaked at $33.6M in Q4 2025.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.